Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Jakob

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Endocrinology|September 1, 1996
Characterization of 17 beta-hydroxysteroid dehydrogenase IVJ F Carstensen, J G Tesdorpf, M Kaufmann, et al.
Journal of Clinical Medicine|August 14, 2025
Management of Aberrant Internal Carotid Artery Injury Caused During Otologic Procedures: Systematic Review and Multicenter Case SeriesAndreas Spörlein, Susan Arndt, Till F Jakob, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 13, 2016
Whole-body electromyostimulation to fight sarcopenic obesity in community-dwelling older women at risk. Resultsof the randomized controlled FORMOsA-sarcopenic obesity studyW Kemmler, M Teschler, A Weissenfels, et al.
Steroids|January 1, 1997
Steroids, fatty acyl-CoA, and sterols are substrates of 80-kDa multifunctional proteinJ Adamski, F Leenders, J F Carstensen, et al.
The New England Journal of Medicine|January 5, 2002
Octreotide therapy for tumor-induced osteomalaciaJ Seufert, K Ebert, J Müller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 31, 2007
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)C Cooper, F Jakob, C Chinn, et al.
Bone|March 5, 2013
Compound heterozygosity of two functional null mutations in the ALPL gene associated with deleterious neurological outcome in an infant with hypophosphatasiaC Hofmann, J Liese, T Schwarz, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2010
Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)A Fahrleitner-Pammer, B L Langdahl, F Marin, et al.
QJM : Monthly Journal of the Association of Physicians|July 25, 2006
Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)F Jakob, F Marín, E Martín-Mola, et al.
European Journal of Endocrinology|November 4, 2011
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational StudyF Jakob, H Oertel, B Langdahl, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Endocrinology|September 1, 1996
Characterization of 17 beta-hydroxysteroid dehydrogenase IVJ F Carstensen, J G Tesdorpf, M Kaufmann, et al.
Journal of Clinical Medicine|August 14, 2025
Management of Aberrant Internal Carotid Artery Injury Caused During Otologic Procedures: Systematic Review and Multicenter Case SeriesAndreas Spörlein, Susan Arndt, Till F Jakob, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 13, 2016
Whole-body electromyostimulation to fight sarcopenic obesity in community-dwelling older women at risk. Resultsof the randomized controlled FORMOsA-sarcopenic obesity studyW Kemmler, M Teschler, A Weissenfels, et al.
Steroids|January 1, 1997
Steroids, fatty acyl-CoA, and sterols are substrates of 80-kDa multifunctional proteinJ Adamski, F Leenders, J F Carstensen, et al.
The New England Journal of Medicine|January 5, 2002
Octreotide therapy for tumor-induced osteomalaciaJ Seufert, K Ebert, J Müller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 31, 2007
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)C Cooper, F Jakob, C Chinn, et al.
Bone|March 5, 2013
Compound heterozygosity of two functional null mutations in the ALPL gene associated with deleterious neurological outcome in an infant with hypophosphatasiaC Hofmann, J Liese, T Schwarz, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2010
Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)A Fahrleitner-Pammer, B L Langdahl, F Marin, et al.
QJM : Monthly Journal of the Association of Physicians|July 25, 2006
Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)F Jakob, F Marín, E Martín-Mola, et al.
European Journal of Endocrinology|November 4, 2011
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational StudyF Jakob, H Oertel, B Langdahl, et al.
Pageof 13